Cadenza is a biotechnology company focused on developing precision therapies for neurodegenerative diseases. The company leverages a combination of computational biology, machine learning, and drug development expertise to identify novel targets and create treatments that can slow or halt disease progression.

Cadenza

Cadenza Bio, Inc. was founded in 2022 to accelerate and support the development of a series of novel, non-steroidal, highly selective compounds targeting Estrogen Receptor β (ERβ). Our patented and patent-pending compounds have shown therapeutic efficacy in preclinical animal models of Multiple Sclerosis and Endometriosis.

Our goal goes beyond incremental improvements. We are dedicated to breaking the cycle of disease and, in doing so, transforming lives. We aim not only to alleviate symptoms but to halt progression, promote repair, and restore quality of life to enable total activity, empowering patients to regain control over their health.

Cadenza Bio

Discover our latest 'Why We Invested' blog spotlighting Cadenza Bio, authored by our Analyst, Mansi Patel.  Delve into Cortado Ventures' recent investment in Cadenza Bio, an Oklahoma-based life sciences company revolutionizing therapeutic solutions for demyelinating diseases like multiple sclerosis (MS). Explore the innovative technology behind Cadenza Bio's approach, the unmet medical needs it addresses, and the compelling reasons behind Cortado's investment decision. #investment #lifesciences #multiplesclerosis
 Carol Curtis, Ph.D.  Elaine H. 
 
Read more: https://lnkd.in/gfEE8zfc

"My scientific career has been dedicated to understanding molecular mechanisms mediated through nuclear receptors in disease states. My desire to get novel therapeutics into the marketplace for these diseases has led me to join Cadenza Bio. Here, I get to bridge my love of nuclear receptors with the goal of getting life-changing treatments into the hands of suffering patients." - Jamie Boney-Montoya - Director, Research & Development 

Brain Awareness Week is a worldwide initiative that aims to increase awareness and knowledge about brain research and the progress made in the field of neuroscience. It provides an opportunity to learn more about the intricacies of the brain and how we can sustain its optimal functioning and health. Discover more about how you can participate by visiting: https://lnkd.in/g-Mwprq8

#BrainAwarenessWeek #CadenzaBio #BrainHealth

Raising awareness about Multiple Sclerosis (MS) is immensely important because it helps educate the public about the symptoms, challenges, and impact of this condition. This knowledge can reduce the stigma surrounding MS and promote early diagnosis, leading to timely access to appropriate medical care. Raising awareness can also encourage research and funding for finding better treatments and ultimately a cure for MS. It is essential for fostering empathy, support, and progress in the fight against this debilitating condition. Together, we can make a significant difference. 

#multiplesclerosis #msawareness #chronicillness #cadenzabio

Endometriosis is a chronic condition that affects millions of women worldwide. The exact cause is still unknown, and further research can help uncover potential risk factors and develop more effective treatments. It significantly impacts a person's well-being, so investing in research can improve their quality of life. Raising awareness can combat misinformation and stigma, leading to earlier diagnosis and better support systems. Let us promote accurate information and understanding to empower individuals and foster a compassionate society. To learn more about endometriosis, we recommend watching "Below The Belt: The Last Health Taboo" which can be found here: https://lnkd.in/gDab2BST

#endometriosisawareness #awarenessmonth #endometriosis #cadenzabio

Metric
Company Name	Cadenza
Symbol
MSH ID	BIO:CADENZA
Market	PRIVATE
Sector	Healthcare & Health Services
Industry	Biotechnology
Country
Stage	Seed
Employee Count	4
Website	cadenza.bio
LinkedIn	cadenza-bio
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic	43
Web Traffic Growth
Valuation
Raised Capital	2.44M

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

BIO:CADENZA

Cadenza

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue